A case of successful treatment of a rare retinal disease presented by interferon-induced retinopathy.

Q4 Medicine

Wiadomosci lekarskie Pub Date : 2024-01-01 DOI:10.36740/WLek202403117

Bohdan M Patskan, Valerii D Beliayev, Kateryna V Bora, Nataliia V Bondarenko

{"title":"A case of successful treatment of a rare retinal disease presented by interferon-induced retinopathy.","authors":"Bohdan M Patskan, Valerii D Beliayev, Kateryna V Bora, Nataliia V Bondarenko","doi":"10.36740/WLek202403117","DOIUrl":null,"url":null,"abstract":"Objective: Aim: To showcase a rare retinal lesion and the results of contemporary diagnostic and treatment of interferon-induced retinopathy.Patients and methods: Materials and Methods: We describe a case of a 36-year-old patient with interferon-induced retinopathy, with hepatitis C, that received prolonged interferon treatment. Clinical signs, examination and combined laser and pharmacologic treatment were showcased in the study.Results: Results: As a result of pharmacologic and laser treatment, the patient's visual acuity increased from 0.1 to 1.0 through the duration of 3 months after treatment. The patients` condition remained stable under dynamic observation.Conclusion: Conclusions: Because interferon-induced retinopathy is a rare occurrence in routine ophthalmologic practice, combined laser therapy can be used for treatment of preretinal hemorrhage, which leads to improvement of visual functions and stabilization of the retinal processes. This case is an addition to the few described cases of interferon-induced retinopathy.","PeriodicalId":23643,"journal":{"name":"Wiadomosci lekarskie","volume":"77 3","pages":"491-496"},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Wiadomosci lekarskie","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36740/WLek202403117","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

Objective: Aim: To showcase a rare retinal lesion and the results of contemporary diagnostic and treatment of interferon-induced retinopathy.

Patients and methods: Materials and Methods: We describe a case of a 36-year-old patient with interferon-induced retinopathy, with hepatitis C, that received prolonged interferon treatment. Clinical signs, examination and combined laser and pharmacologic treatment were showcased in the study.

Results: Results: As a result of pharmacologic and laser treatment, the patient's visual acuity increased from 0.1 to 1.0 through the duration of 3 months after treatment. The patients` condition remained stable under dynamic observation.

Conclusion: Conclusions: Because interferon-induced retinopathy is a rare occurrence in routine ophthalmologic practice, combined laser therapy can be used for treatment of preretinal hemorrhage, which leads to improvement of visual functions and stabilization of the retinal processes. This case is an addition to the few described cases of interferon-induced retinopathy.

查看原文本刊更多论文

成功治疗一例由干扰素诱发的罕见视网膜病变。

目的目的：展示一种罕见的视网膜病变以及干扰素诱导的视网膜病变的当代诊断和治疗结果：材料与方法：我们描述了一例长期接受干扰素治疗的 36 岁丙型肝炎干扰素诱导性视网膜病变患者。研究中展示了临床症状、检查以及激光和药物联合治疗：结果：结果：通过药物和激光治疗，患者的视力在治疗后 3 个月内从 0.1 提高到 1.0。在动态观察下，患者的病情保持稳定：结论由于干扰素诱发的视网膜病变在眼科常规治疗中较为罕见，因此可采用激光联合疗法治疗视网膜前出血，从而改善视功能，稳定视网膜过程。本病例是为数不多的干扰素诱发视网膜病变病例的补充。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Wiadomosci lekarskie Medicine-Medicine (all)

CiteScore

0.80

自引率

0.00%

发文量

482